RESULTS Hydroxypropyl cellulose is extensively used in tablets, capsules, mucous membrane adhesion preparation, sustained or controlled release preparation, and film coating, etc.
结果羟丙基纤维素在片剂、胶囊剂、黏膜黏附制剂、缓控释制剂等多种制剂以及薄膜包衣方面均有良好应用。
OBJECTIVE Study on preparation technology of Jingangteng Chewable Tablets.
目的研究金刚藤咀嚼片的制备工艺。
Objective To study the formulation of Salvianolic Acid Orally Disintegrating Tablets and preparation process.
目的对丹参多酚酸口腔崩解片的制剂处方和制备工艺进行研究。
OBJECTIVE To improve the preparation technology of Jianyang Tablets, and ensure the quality of the drug.
目的对健阳片制备工艺进行改进，确保健阳片的生产质量。
OBJECTIVE To study preparation process of Glucosamine Sulfate Dispersable Tablets.
目的研究硫酸氨基葡萄糖分散片制备处方和工艺。
Result: Konjack glucomannan can be used in the preparation of the aspirin tablets.
结果：在阿司匹林片制备中可以使用魔芋葡甘露聚糖。
Objective To optimize preparation process of Naoxuekang dispersible tablets.
目的优化脑血康分散片的制备工艺。
Objective: To investigate the preparation technique and optimal formulation of Qingkailing dispersible tablets.
目的：考察清开灵分散片的制备工艺和最优处方。
CONCLUSION The is sustained release tablets could be developed as new preparation.
结论：曲匹地尔缓释片剂可作为曲匹地尔的新制剂开发。
OBJECTIVE: Improved preparation process of ibuprofen tablets.
目的：对布洛芬片制备工艺进行改进。
OBJECTIVE: to preparation loratadine tablets and to establish a methods of quality for it.
目的：制备氯雷他定片并建立其质量控制方法。
METHODS: The dissolution rates of Radix Notoginseng total Saponin Dispersible tablets and Xueshuantong preparation were determined by HPLC.
方法：采用高效液相色谱法测定我们制备的三七总皂苷分散片和血栓通制剂的溶出度。
The formulation, preparation process and dissolution rate in vitro of Sustained-Release Aspirin tablets(S-RAT)were studied.
本文研究了阿司匹林缓释片（S-RAT）的处方组成、制备工艺、体外溶出速率试验。
OBJECTIVE : To prepare an effervescent tablets of ofloxacin and establish quality preparation.
目的：研制氧氟沙星泡腾片并建立该制剂的质量控制标准。
The Compound Danshen Capsules made by novel preparation process are superior to Compound Danshen Tablets in respects of preparation pro - cess, quality control and clinical observation.
在制备工艺、质量控制、临床观察等方面均优于复方丹参片。
Results: The qualification rate of tablets, capsules, external preparation, liquid preparation and injectable preparation were 86.6%, 78.5%, 85.7%, 75% and 75% respectively.
片剂说明书合格率为86.6%，胶囊剂说明书合格率为78.5%，外用制剂合格率为85.7%，液体制剂合格率为75%，注射剂合格率为75%。
This paper reviewed the recent progress in preparation craft of osmotic pump controlled release tablets.
本文就口服渗透泵型控释片的制备工艺研究进展情况进行了综述。
Successive Approximation Spectrometry method has been developed and it has been studied in application of compound preparation by compound APC tablets and Andoyne tablets.
本文建立了逐步逼近分光光度法，并以复方乙酰水杨酸片和去痛片为对象就该法在复方制剂组分含量测定中的应用进行了研究。
OBJECTIVE To optimize the preparation of dispersible tablets using central composite design.
目的中心组合设计法优化独一味分散片制备处方。
The invention also provides a preparation method for the mangiferin dispersible tablets.
本发明还提供所述芒果苷分散片的制备方法。
OBJECTIVE: To optimize the preparation technics and the formula of gatifloxacin dispersible tablets.
前言：目的：考察及筛选加替沙星分散片的制备工艺和最优处方。
Results: The preparation way and quality control standard of Manshenning tablets have been established.
结果：建立了慢肾宁片的制备方法和质量标准。
Objective To investigate the composition and preparation method of galanthamine hydrobromide dispersion tablets.
目的研究氢溴酸加兰他敏分散片的处方组成及制备工艺。
Objective: To discuss the dispersible tablets preparation of radix puerariae isoflavone.
目的：探讨葛根异黄酮分散片的制备工艺。
OBJECTIVE: To prepare an effervescent tablets of ofloxacin and establish quality preparation.
前言：目的：研制氧氟沙星泡腾片并建立该制剂的质量控制标准。
OBJECTIVE To study the formulation, preparation and dissolution of amoxicillin and clavulanate potassium tablets.
目的：研究阿莫西林克拉维酸钾片处方及工艺，并考察其溶出度。
During the processing and preparation, the ingredients are uniformly and proportionally mixed, and are then prepared into capsules or tablets by a conventional preparation method.
加工制作时将其按比例混合均匀，再以常规制剂的方法制成胶囊或片剂。
CONCLUSION: the formula is reasonable and the preparation technic simple. The prepared tablets are suitable for clinical use.
结论：本法处方合理，工艺简单，所制备的银黄酮片适合临床应用。
CONCLUSION: the formula is reasonable and the preparation technic simple. The prepared tablets are suitable for clinical use.
结论：本法处方合理，工艺简单，所制备的银黄酮片适合临床应用。
应用推荐